(Q54359584)

28 May 2018

title

Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients. (English)

1 reference

28 May 2018

0 references

1 reference

Molina JA

1

1 reference

28 May 2018

Benito-León J

2

1 reference

28 May 2018

Jiménez-Jiménez FJ

3

1 reference

28 May 2018

Ortí-Pareja M

4

1 reference

28 May 2018

Berbel A

5

1 reference

28 May 2018

Tallón-Barranco A

6

1 reference

28 May 2018

de Bustos F

7

1 reference

28 May 2018

Hernánz A

8

1 reference

28 May 2018

language of work or name

English

0 references

publication date

1 December 1997

1 reference

28 May 2018

published in

Neuroscience Letters

1 reference

28 May 2018

volume

238

1 reference

28 May 2018

issue

3

1 reference

28 May 2018

page(s)

139-141

1 reference

28 May 2018

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Neurodegenerative disorders with extensive tau pathology: a comparative study and review

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

A Population-Based Investigation of Parkinson's Disease With and Without Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900858-6

7 January 2021

10.1016/S0304-3940(97)00858-6

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018